FIRMQUARRYResearch workspace

GOVERNMENT CONTRACT / PURCHASE ORDER

NEXT GENERATION SEQUENCING (NGS) REAGENTS [22-009464]

Awarded to CAREDX LAB SOLUTIONS INC

PIID 75N90022P00648US · USAspendingOther
$34K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$33,990sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateSep 28, 2022
Company legal name
CAREDX LAB SOLUTIONS INC
UEI / CAGE
KHHBJ9FJR225 / Not reported
Parent award
Not reported
Awarding agency
Department of Health and Human Services
Subagency
National Institutes of Health
Industry
Other
NAICS
325413
PSC
6550
Performance period
Not reported — Not reported
Recipient address
901 S BOLMAR ST, WEST CHESTER, CHESTER, PA, 19382
Place of performance
WEST CHESTER, CHESTER, PA, 19382
Source last modified
Nov 3, 2026

Description

NEXT GENERATION SEQUENCING (NGS) REAGENTS [22-009464]

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    NEXT GENERATION SEQUENCING (NGS) REAGENTS [22-009464]

    US · usaspendingSource ↗
  2. Value increased

    NEXT GENERATION SEQUENCING (NGS) REAGENTS [22-009464]

    US · usaspending$34KSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Sep 28, 20220Not reported$33,990.00Not reportedNot reportedNEXT GENERATION SEQUENCING (NGS) REAGENTS [22-009464]USAspending ↗